Morgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Ricky Goldwasser maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the price target from $308 to $338.
Morgan Stanley analyst Ricky Goldwasser maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the price target from $308 to $338.